openPR Logo
Press release

“Global translational regenerative medicine market set to grow to $95bn by 2024,” says Visiongain

05-24-2019 11:53 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: visiongain

Your guide to your industry

Your guide to your industry

Visiongain has published a new Pharma Report Top 25 Translational Regenerative Medicine Manufacturers 2019: Medtronic, Acelity, Integra Lifesciences, NuVasive, Orthofix International, Anika Therapeutics, Organogenesis, UniQure, TiGenix, Vericel Corporation and other Companies.

In 2018, the global translational regenerative medicine was estimated to be worth $28bn. The global translational regenerative medicine market is highly competitive and fragmented with the presence of several vendors. Competition is likely to increase with advances in R&D and technological innovations. The market is characterised by the presence of well-diversified international and local vendors that provide cost-effective products with limited features and functionalities.

Download free report sample pages:

This report profiled the selected companies: Medtronic, Acelity, Integra Lifesciences, NuVasive, Orthofix International, Anika Therapeutics, Organogenesis, UniQure, TiGenix, Vericel Corporation and other selected companies.

If you are interested in a more detailed overview of this report, please send an e-mail to or call her on 020 7549 9987

The lead analyst commented that “Advancements in biological sciences have shown a positive influence on the regenerative medicine market. There are new technological advancements in terms of drug manufacturing, development, and delivery. Many cell therapy products based on mesenchymal stem cells are available in the market because of their self-renewal ability and their presence in almost all tissues. The discovery of novel scaffolds and various growth and control factors have shown promising results in stimulating tissue formation. This has led to a shift in the focus to regenerative therapies over conventional methods of treatment.”

Related reports:

Global Cancer Immunotherapy Market Forecast 2019-2029:

Global Biosimilars and Follow-On Biologics Market 2019-2029:

Translational Regenerative Medicine Market Forecast 2019-2029:

For more pharma reports, visit our website:

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to or call her on 020 7549 9987

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, we produce a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Visiongain Limited
Airport House
Purley Way
United Kingdom

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release “Global translational regenerative medicine market set to grow to $95bn by 2024,” says Visiongain here

News-ID: 1752357 • Views: 519

More Releases from visiongain

Newly Published Visiongain Report: Top 20 Geothermal Power Companies 2019
Profiles of Leading Companies Operating Within the Geothermal Power Market Including Financial and Market Share Analysis (Capacity MW, $million) Plus Tables Outlining Major Projects in Various Regions Purchase full report or download free sample pages: Geothermal energy is a clean and renewable energy derived from the heat produced by the slow decay of radioactive particles in the core of the earth. Geothermal reservoirs are located deep underground and can be detected through
Newly Published Visiongain Report: Supersonic and Hypersonic Missiles Market Rep …
Forecasts & Analysis by Platform (Land, Naval, Aerial), Forecasts & Contract Tables for Leading Countries (China, United States, UK, Russia, Japan, India, Germany, France, Australia, ROW), Plus Analysis of Leading Companies (Aerojet, Boeing, Brahmos, CASIC, Elbit, Kratos, Lockheed Martin, MBDA, Northrop Grumman, Raytheon, SAAB, Tactical Missile Corporation, Zircon, Brahmos) Purchase full report or download free sample pages: o Do you need definitive Supersonic and Hypersonic Missiles market data? o Succinct Supersonic and Hypersonic
Newly Published Visiongain Report: Ultra-Thin Solar Cells Market Report 2019-202 …
Forecasts by Type (Cadmium Telluride (CdTe), Copper Indium Gallium Diselenide (CIGS), Amorphous Thin-Film Silicon (ATFS), Others), by Installation (On-Grid, Off-Grid) and by Application (Industrial, Residential, Commercial, Utility, Others) Plus Financial Analysis of Leading Companies and Regional and Leading National Market Analysis Purchase full report or download free sample pages: o Do you need definitive Ultra-Thin Solar Cells market data? o Succinct Ultra-Thin Solar Cells market analysis? o Technological insight? o Clear competitor analysis? o Actionable business
New Visiongain Report: Automotive Driver Monitoring System (DMS) Market Report 2 …
Forecasts & Analysis by Product Type (Camera Based and Sensor Based), by Vehicle Type (Passenger Vehicle, LCV, HCV), by Geography (America, Asia Oceania, Europe, MEA) Plus Profiles of Leading Companies Developing Biometrics Technologies for Advanced Driver Assistance Systems (ADAS) Purchase full report or download free sample pages: Driver Monitoring Systems (DMS) are being developed to monitor driver alertness, that not only recognizes the driver, but also checks his or her level of

All 5 Releases

More Releases for Translational

Visiongain states that “Translational regenerative medicine market set to grow …
Visiongain’ has launched a new pharma report: Translational Regenerative Medicine Market Forecast 2019-2029: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies. The high potential earning for companies from products aimed at repairing organs and tissues has led to an increase in the attention given to regenerative medicine research. Regenerative medicine (RM) is viewed as possessing the ability to provide therapeutic products targeted at multiple disease classes, such as cardiovascular, dermatological, and orthopaedic
Mice Model Market - Game-Changing Animal Research Models Offer Superior Translat …
Mice model has become one of the essential model for dealing with human pathophysiology and disease progression owing to remarkable resemblances between the genetics, anatomy, and physiology mice and humans. These similarities promote mechanisms of different diseases, understanding of the functions of individual genes, scientific discovery, and the effectiveness and toxicities of various drug molecules. The mouse is the only mammal which offers a rich source for extensive genome manipulation coupled
Bruker Unveils Next-Generation Preclinical Imaging Systems for Advanced Translat …
New, highest-performance microCT system and novel SiPM PET insert for simultaneous PET/MRI introduced NEW YORK, New York – September 7, 2016 – Bruker today unveils two new preclinical imaging systems at the World Molecular Imaging Congress 2016 (WMIC: in New York. The new systems are designed to deliver highest performance and improved convenience for routine imaging, and enable novel translational research into the causes, progression, as well as potential
Translational Imaging to improve probability of success in drug development
Join SMi at their 8th annual Imaging in Cancer Drug Development conference that promises to be interactive and informative. With an increasing verity of imaging modalities available and each of them offering benefits at different stages and in different ways, there is a great deal of benefit that can be gained from their implementation. You will hear from industry experts on the current applications of imaging in all stages of drug
Strand and Narayana Hrudalaya Collaborate in Translational Cancer Research
First-of-its kind project in translational cancer research aimed to produce pioneering discoveries and affordable clinical solutions in cancer care. August 19, 2010, Bangalore, India – Strand Life Sciences (Strand), a technology pioneer in the practice of scientific intelligence in health sciences, today announced that it has signed an MOU with Mazumdar Shaw Comprehensive Cancer Centre (MSCC) of the Narayana Hrudalaya (NH), in translational cancer research. The partnership is aimed at performing
Definiens to Present Image Analysis Software for Clinical Trials and Translation …
Munich, Germany / Parsippany, New Jersey – June 1, 2010 – Definiens, the number one Enterprise Image Intelligence® company, will present its image analysis software for use in clinical trials and translational research at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL, from June 4th to 8th. Definiens software enables personalized medicine by providing oncology researchers and drug developers with deeper insights into